Deep Venous Disease Treatment Devices – Market Insights – Global

The uptake of innovative higher-priced powered thrombectomy devices, together with the increasing use of PE treatment procedures—both supported by favorable clinical data—will drive strong growth in the global deep venous disease treatment device market over the forecast period. However, insufficient reimbursement and local competitors with more competitive pricing options in regions other than the US will hinder the pace of market expansion to some extent.

This Medtech 360 Report provides comprehensive data and analysis on the state of the global market for deep venous disease treatment devices from 2019 through 2034.

Market growth will be primarily driven by the powered thrombectomy device market, supported by rising procedure volumes and premium pricing.

How will the use of powered thrombectomy devices impact other alternatives for treating VTE?

What is the outlook for treatment trends for DVT and PE?

Will other thrombectomy and thrombolysis procedures, such as CDT, follow similar trends?

To what extent has this affected the competitive landscape?

Competitive efforts conducted by key manufacturers focus on generating clinical evidence and innovative products.

Which ongoing clinical trials are most relevant, and to what extent will they impact future trends? Are head-to-head clinical trials being conducted?

How has the evidence generated for powered thrombectomy devices and PV stents impacted the competitive landscape?

Which factors are influencing the adoption of dedicated venous stents?

How will product improvements and improved patient management contribute to growth?

Key manufacturers will strengthen their position globally through M&A activities and partnerships.

Which acquisitions have been the most relevant so far?

How will distribution agreements affect the competitive landscape in certain regions?

Limited use of premium-priced devices in some countries limits market growth to some extent.

Will competitive or regulatory pressures on ASPs make premium-priced devices more affordable?

How will the presence of lower-priced devices from local competitors affect the competitive landscape in these countries?